Azacicolcept (ALPN-101) 是一种 Fc 融合蛋白,是一种双重诱导型 T 细胞共刺激物 (ICOS)/CD28拮抗剂。Azacicolcept 具有抗炎活性。
生物活性 | Acazicolcept (ALPN-101), an Fc fusion protein, is a dualinducible T cell costimulator (ICOS)/CD28antagonist. Acazicolcept has anti-inflammatory activities[1]. |
体内研究 (In Vivo) | Azacicolcept (267-400 μg/mouse; i.p.; twice a week; for 6 weeks) 可减少皮肤和肺纤维化并缓解肺动脉高压[1]。
Animal Model: | Six-week-old female BALB/c mice induced by hypochlorous acid (HOCL)[1] | Dosage: | 267 μg/mouse and 400 μg/mouse | Administration: | i.p.; twice a week; for 6 weeks | Result: | Induced a significant decrease in dermal thickness, collagen content, myofibroblast number, and inflammatory infiltrates characterized by B cells, T cells, neutrophils, and macrophages. |
|
CAS 号 | |
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |